[PSY110] Horizontal Vs. Vertical Equity: Market Access of Orphan Drugs In France and Uk
2015 Value in Health
Korchagina, D. | Tavella, F. | Rémuzat, C. | Toumi, M. | Falissard, B. |
In 2000 EU introduced an orphan legislation in order to stimulate the development of drugs for rare diseases. Nevertheless, the actual availability of orphan drugs (ODs) in the EU depends on national authorities. The study aims to compare OD availability and market access in France and the UK.